Photrexa cross-linking kit 6ML
Ended Awarded
- Contract number
- SPE2DR26FHNQ1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,817
Award facts
- Contract value 100% obligated
- $2,816.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,816.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of a Photrexa Cross-Linking Kit (6ML). The contract is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and was issued without a set-aside designation. DMS Pharmaceutical Group will perform the work at its facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a ceiling value of $499.999 billion and extends through December 31, 2036. The broader PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense military healthcare facilities worldwide. Under this IDC structure, DLA issues firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support the recurring medical supply needs of military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FHNQ1?
SPE2DR26FHNQ1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FHNQ1 worth?
The government has obligated $2,817 on SPE2DR26FHNQ1.
Is contract SPE2DR26FHNQ1 an order under another contract?
Yes. SPE2DR26FHNQ1 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNQ1 competed?
The extent of competition for SPE2DR26FHNQ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award